RITT yields 2000000.00% · JNJ yields 2.13%● Live data
📍 RITT pulled ahead of the other in Year 1
Combined, RITT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RITT + JNJ for your $10,000?
RiT Technologies Ltd. provides intelligent infrastructure management (IIM) and indoor optical wireless technology solutions worldwide. The company's IIM products enhance security and network utilization for data centers, communication rooms, and work space environments. Its enterprise solutions include PatchView hardware, which is offered in a cross connect topology; CenterMind data center management software that supports the monitoring of power distribution units, and environmental parameters in data centers; and SMART Cabling System, a structured network infrastructure solution designed for copper and fiber cabling environments. It also offers Beamcaster, an indoor wireless optical solution that allows high-speed, high-bandwidth transmission through optical signals between the central station and the user station. The company's solutions are deployed in a range of organizations, including data centers in the private sector, government agencies, financial institutions, airport authorities, healthcare, and education institutions. RiT Technologies Ltd. markets its products through independent distributors, resellers/integrators, original equipment manufacturers, and other strategic alliance partners with companies. The company was founded in 1989 and is headquartered in Tel Aviv, Israel. RiT Technologies Ltd. operates as a subsidiary of Stins Coman Incorporated.
Full RITT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.